Results of myocardial scintigraphy with 99mTc-tetrofosmin and dypiridamole administration in patients diagnosed of microvascular angina;Resultados de la gammagrafía de perfusión miocárdica con 99mTc-tetrofosmina y estímulo con dipiridamol en pacientes diagnosticados de angina microvascular

Revista Espanola de Medicina Nuclear

Volumn 19, Issue 5, 2000, Pages 337-343

  Ortega, Ana ^a   Moreno, R ^a   Alonso, J C ^a   Dominguez P ^a   Almoguera, I ^a   Bittini, A ^a   Lampreave, J L ^a   Suarez M ^a   Gomez A ^a   Martinez L ^a   Sosa, V ^a   Sarnago, F ^a   Garcia Fernandez M A ^a   Perez Vazquez J M ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Microvascular angina; Myocardial scintigraphy

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; MALE; PHARMACOLOGICAL STIMULATION; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNDROME X; TREADMILL EXERCISE; CORONARY ARTERY BLOOD FLOW; HEART; MIDDLE AGED; RETROSPECTIVE STUDY; SCINTISCANNING;

CORONARY CIRCULATION; DIPYRIDAMOLE; FEMALE; HEART; HUMANS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 0034265572     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/S0212-6982(00)71887-8     Document Type: Article

References (28)

1. Maseri A, Crea F, Kaski C, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991;17:499-506.
2. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659-64.
3. Geltman EM, Henes CG, Senneff MJ, Sobel BE, Bergman SR. Increased myocardial perfussion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol 1990;16:586-95.
4. Cannon RO, Bonow RO, Bacharach SL, Green MV, Rosing DR, Leon MB, et al. Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries and abnormal vasodilation reserve. Circulation 1985;71:218-26.
5. 99mTc Sestamibi myocardial SPECT in symdrome X. Clin Nucl Med 1996;21:280-3.
6. 201Tl myocardial SPECT in strictly defined syndrome X. Nucl Med Commun 1995;16:640-6.
7. Tweddel AC, Martin W, Hutton I. Thallium scans in syndrome X. Br Heart J 1992;68:48-50.
8. Legrand V, Hodgson JM, Bates ER, Aueron FM, Mancini GBJ, Smith JS, et al. Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms. J Am Coll Cardiol 1985;6:1245-53.
9. 201Tl myocardial single-photon emission computed tomography. J Am Coll Cardiol 1996;28:890-6.
10. Iosseliani D, Kluchnikov I, Koval A, Smirnov M, Bhattacharya P. X-syndrome: is there impairment of myocardial perfusion during stress? Int J Card Imaging 1994;10:149-53.
11. Wallamies M, Kaskinen M, Vusitalo A, Niemela K. Inhomogeneous exercise uptake and accelerated washout of a radioiodinated fatty accid analogue in syndrome X. A SPECT study of the left ventricle. Int J Card Imaging 1994;10:123-9.
12. 201Tl reverse redistribution phenomenon in patients with syndrome X. Eur Heart J 1996;17:1482-7.
13. 201Tl en pacientes con síndrome X. Rev Esp Med Nucl 1999;18:331-5.
14. Beller GA. Radiopharmaceuticals in nuclear cardiology. En: Beller GA, ed. Clinical nuclear cardiology. Philadelphia: W.B. Saunders Company; 1995. p. 37-81.
15. 99mTc-tetrofosmin y estímulo con dipiridamol en pacientes bloqueo completo de rama izquierda del haz de His. Rev Esp Med Nucl 2000;19:3-10.
16. Meeder JG, Blanksma PK, van der Wall EE, Willemssem AT, Pruim J, et al. Coronary vasomotion in patients with syndrome X: evaluation with positron emission tomography and parametric myocardial perfusion imaging. Eur J Nucl Med 1997;24:530-7.
17. Buus NH, Bottcher M, Bottker HE, Sorensen KE, Nielsen TT, Mulvany MJ. Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteries. Am J Cardiol 1999;83:149-54.
18. Lanza GA. Abnormal cardiac nerve function in syndrome X. Herz 1999;24:97-102.
19. Rosano GM, Ponikowski P, Adamopoulos S, Collins P, Poole-Wilson PA, Coats AJ, et al. Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol 1994;73:1174-9.
20. Tousoulis D, Crake T, Lefroy DC, Galassi AR, Maseri A. Left ventricular hypercontractility and ST segment depression in patients with syndrome X. J Am Coll Cardiol 1993;22:1607-13.
21. Moreno R, García-Fernández MA, Moreno M, Puerta P, Ortega A, Delcán JL. Systolic and diastolic abnormalities found by pulsed-wave Doppler Tissue Imaging in patients with microvascular angina. Echocardiography 1999;16:239-44.
22. Kaski JC, Atienza F. Angina de pecho con angiografía coronaria normal. Síndrome X cardíaco. En: Iriarte MM. Cardiopatía hipertensiva; 1997. p. 179-86.
23. Galassi AR, Crea F, Araujo LI, Lammertsma AA, Pupita G, Yamamoto Y, et al. Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease. Am J Cardiol 1993;72:134-9.
24. Romeo F, Rosano GMC, Martuscelli E, Lombardo L, Valente A. Long-term follow-up of patients initially diagnosed with syndrome X. Am J Cardiol 1993;71:669-73.
25. Candell-Riera J, Castell J, Ortega D. Estudios radioisotópicos en los pacientes con dolor torácico y coronarias angiográficamente normales. Rev Lat Cardiol 1990;11:59-64.
26. 99mTc-MIBI-SPECT. Nuklearmedizin 1996;35:193-7.
27. 99mTc-tetrofosmin. Rev Esp Med Nucl (en prensa).
28. Sarnago F, Calvo J, García E, San Román D, Abeytua M, Delcán JL. Angina de pecho por trastornos de la microcirculación coronaria. Clin Cardiovasc 1992;10:82-7.